Trial intelligence / Profile preview

Probiotics for Gallstones in Post-bariatric Surgery Patients

NCT03247101Unknown

Sponsor
Min-Sheng General Hospital
Start
Feb 2016
Primary completion
Dec 2017
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Trial of clostridium butyricum in cholelithiasis (3 arms), sponsored by Min-Sheng General Hospital. Primary endpoint: Gallstones formation at 6 months. Status: unknown.

02

Drugs

clostridium butyricum
03

Conditions

cholelithiasis

Beyond the preview

Go deeper on NCT03247101.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03247101.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call